Remove Pharma Quality Remove Production Remove Research Remove Trials
article thumbnail

Why should pharma invest in digital products for those living with rare diseases?

pharmaphorum

Consultations and clinical trials are often few and far between. Research in rare diseases will benefit from identifying cause and effect, which consider behaviours, social economics, and the patient’s emotional state. New digital products always rely on early adopters to create a community and improve the product.